Breaking News

Telehealth policies under review by lawmakers

April 11, 2024
Health Tech Correspondent

Good morning health tech readers!

Today, a focus on telehealth with a dash of AI and VR. To the future of health care we go.

Reach me: mario.aguilar@statnews.com

medicine

How telehealth providers can drive antibiotic overuse

More than a quarter of outpatient antibiotics are inappropriately prescribed, and as STAT's Katie Palmer writes, telehealth could exacerbate the problem: Studies have suggested that virtual visits, on average, result in more antibiotic prescribing than in-person visits. But not all telehealth is created equal — and research is beginning to untangle which approaches are more likely to result in unnecessary antibiotics. In turn, national telehealth guidelines and standards are fighting back by prioritizing safe and effective virtual prescribing practices. These questions come amid bubbling concerns about the safety and necessity of telehealth prescribing in general.

Read more here


policy

Lawmakers huddle on telehealth bills

The House Energy and Commerce Subcommittee on Health is considering more than a dozen bills as it races to beat the December 31 expiration date for some pandemic virtual care flexibilities, such as easing requirements for the patient's location during telehealth visits. With mountains of data from the past few years on telehealth's impact on cost, fraud and safety, lawmakers appear closer than ever before to establishing more permanent policies.

My colleague Mohana Ravindranath tells us that during a hearing yesterday, Health subcommittee chair Brett Guthrie (R-KY) acknowledged that fraud and abuse cases haven't proliferated in telehealth as much as critics expected, citing recent data from the Health and Human Services Department's Office of the Inspector General. "It appears that telehealth can be used to deliver care without actually raising those serious concerns," he said.

Cost, however, could still be a hurdle in Congress. Permanently extending telehealth flexibilities is likely to cost more than the $2 billion, according the Congressional Budget Office estimate for the previous extension, Guthrie said.

And lawmakers still must also grapple with state licensing restrictions that prevent clinicians from treating patients while they're traveling, for instance.

"Right now, it's creating a lot of a chilling effect, where Physicians are worried that I don't want to abandon my patient, but I am risking my license by caring for them and providing advice over the phone or a over a video visit," said Ateev Mehrotra, a Harvard professor and frequent Congressional witness whose research has often challenged telehealth advocates' assertion that virtual care doesn't impact costs and utilization.


Mental health

How expiring rule could impact telehealth access

Screen Shot 2024-04-11 at 7.10.38 AM

Speaking of Ateev Mehrotra (see above), he has a new paper out in JAMA Health Forum relevant to expiring pandemic telehealth flexibilities — and specifically the currently waived requirement that people on Medicare must be seen in-person prior to receiving mental health treatment over telehealth. Mehrotra and colleagues analyzed initial telemental health visits for people enrolled in traditional Medicare and found that in 2022, after peak pandemic, only about 20% were preceded by an in-person visit. "These findings suggest that Medicare's in-person visit requirement will require substantial
changes in current practice," the authors write. 



artificial intelligence

AI bits from ACC

Beyond huge medical device deals and trial results supporting the use of GLP-1 agonist drugs to combat heart conditions, the American College of Cardiology's big conference last weekend featured a few interesting developments on using artificial intelligence tools to help diagnose heart conditions.

  • Researchers published a study detailing  an AI algorithm that uses echocardiography videos to predict the onset and progression of aortic stenosis, a narrowing of the heart valve. The system, which can use video from easy-to-use handheld devices, holds promise both in managing patients as well as in trials for future treatments. 
  • Viz.ai presented a series of abstracts around the company's algorithm that detects potential hypertrophic cardiomyopathy — a thickening of the heart muscle that can lead to sudden cardiac death — from routine electrocardiograms. The company received Food and Drug Administration clearance for the software last summer, and at the time experts lamented the lack of peer reviewed publications detailing the tool. Two of the ACC abstracts present data about the technology's use at Mass General Brigham and Morristown Medical Center in New Jersey, suggesting Viz HCM's strong performance, including within many demographic groups often excluded from research. 
  • Anumana, which has FDA-cleared software for detecting low-ejection fraction that may indicate heart failure, did not present data so much as the promise of data in the form of two posters. One detailed the design of a multi-center implementation study of its cleared AI-ECG product as well as the design of a study looking at the company's system that helps doctors get heart failure patients on the right cocktail of treatments.

research

Virtual reality vs tablet to improve pain

For many years, researchers have studied the potential of virtual reality-based treatments to help people experiencing pain, and a new study shows its promise to help hospitalized patients experiencing pain from cancer or cancer treatment. The study compared  two calming nature experiences, one delivered on a tablet and one over virtual reality, and found that while patients in both groups reported lower pain severity after a single use, the VR experience had a larger effect. Moreover, the difference in effect persisted to the following day.

One detail caught my eye: The study did not use a a specific intervention packed with cognitive behavioral therapy and special stimuli meant to activate brain regions — it was off-the-shelf software. This suggests, as others have noted in the past, that there may be something therapeutic about simply engaging in a novel virtual reality experience. The next step, according to  researcher Hunter Groninger, of Georgetown University School of Medicine, is to study how VR-based treatment impacts pain over repeated use.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Real-world walking behaviors are associated with early-stage heart failure: a Project Baseline Health Study, Journal of Cardiac Failure
  • Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing, STAT
  • Do 'griefbots' help mourners deal with loss?, UnDark

Thanks for reading! More on Tuesday - Mario

Mario Aguilar covers how technology is transforming health care. He is based in New York.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments